文献速递心血管MR

钆增强T1*比值成像用于心肌组织特征分析的可行性

Feasibility of Gadolinium-enhanced T1* Ratio Mapping for Myocardial Tissue Characterization.
PubMed 文献 · Radiol Cardiothorac Imaging · 2025-01-01

这项回顾性研究纳入2015至2023年接受心脏MRI的130例患者,从标准反转时间预扫描图像生成运动校正的T1*比值图,以脾脏为参考的T1*比值区分疾病组与对照组AUC为0.76,区分心脏淀粉样变与对照组AUC>0.99,与晚期钆增强定量强相关(R=0.85)。

要点

  • 脾脏参考T1*比值区分心脏淀粉样变与对照组AUC>0.99,与其他疾病鉴别AUC=0.97。
  • 脾脏参考T1*比值与LGE定量强相关(R=0.85),显示的心肌受累范围大于LGE。
  • 该后处理算法可整合进现有心脏MRI流程,无需额外序列。

核心结论

  • T1*比值成像在识别多种病理状态下的心肌改变方面显示出潜力,作为后处理算法易于整合到现有流程中,可能促进心肌组织特征分析的广泛应用。

研究设计与样本

  • 回顾性研究,纳入2015至2023年接受心脏MRI检查的130例患者(平均年龄63岁±21[SD],男性90例),包括心脏淀粉样变30例、心肌炎20例、扩张型心肌病20例、肥厚型心肌病30例及健康对照30例;从反转时间预扫描图像生成运动校正的T1*比值图,以血池、骨骼肌和脾脏为参考组织。

关键影像表现/征象

  • 以脾脏为参考的T1*比值在所有参考组织中区分疾病组与对照组的AUC最高(AUC=0.76[95%CI:0.68,0.84])。
  • 脾脏参考T1*比值区分心脏淀粉样变与对照组AUC>0.99(95%CI:>0.99,>0.99)。
  • 脾脏参考T1*比值区分心脏淀粉样变与其他疾病AUC=0.97(95%CI:0.94,>0.99)。
  • 脾脏参考T1*比值区分心肌炎受累与未受累心肌节段AUC=0.93(95%CI:0.86,0.98)。
  • 脾脏参考T1*比值与LGE定量强相关(R=0.85),且在心肌病中显示的心肌受累范围大于LGE(rb=0.22)。

诊断标准与关键数值

  • 脾脏参考T1*比值区分疾病组与对照组AUC=0.76(95%CI:0.68,0.84)。
  • 脾脏参考T1*比值区分心脏淀粉样变与对照组AUC>0.99(95%CI:>0.99,>0.99)。
  • 脾脏参考T1*比值区分心脏淀粉样变与其他疾病AUC=0.97(95%CI:0.94,>0.99)。
  • 脾脏参考T1*比值区分心肌炎受累与未受累节段AUC=0.93(95%CI:0.86,0.98)。
  • 脾脏参考T1*比值与LGE定量相关R=0.85,与LGE范围比较rb=0.22。

临床应用与阅片要点

  • T1*比值图可作为后处理算法整合进现有心脏MRI流程,无需额外采集序列。
  • 脾脏参考T1*比值在心脏淀粉样变中鉴别能力最高,可能用于区分淀粉样变与其他心肌病。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To evaluate the diagnostic performance of T1* ratio mapping, a novel postprocessing algorithm applied to standard inversion time (TI) scout images for cardiac tissue characterization. Materials and Methods This retrospective study included patients who underwent cardiac MRI examinations between 2015 and 2023 and were diagnosed with cardiac amyloidosis (CA), myocarditis, dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), or no disease (healthy controls). Motion-corrected postcontrast T1* ratio maps were generated from TI scout images using blood pool, skeletal muscle, and spleen as reference tissues. Diagnostic performance was evaluated using receiver operating characteristic curve analysis; group differences were assessed with nonparametric tests; and correlations between T1* ratio mapping and late gadolinium enhancement (LGE) quantification were analyzed. Results The study included 130 patients (mean age, 63 years ± 21 [SD]; 90 male patients; 30 with CA, 20 with myocarditis, 20 with DCM, 30 with HCM, and 30 controls). Spleen-referenced T1* ratio showed the highest area under the receiver operating characteristic curve (AUC) of the reference tissues for distinguishing pooled disease cases from controls (AUC = 0.76 [95% CI: 0.68, 0.84]). It achieved excellent discriminatory ability for CA cases versus controls (AUC > 0.99 [95% CI: >0.99, >0.99]), CA versus other pooled diseases (AUC = 0.97 [95% CI: 0.94, >0.99]), and differentiating affected from unaffected myocarditis segments (AUC = 0.93 [95% CI: 0.86, 0.98]). Spleen-referenced T1* ratio strongly correlated with LGE quantification (R = 0.85) and identified a greater extent of myocardial involvement than LGE in cardiomyopathies (rb = 0.22). Conclusion T1* ratio mapping showed potential in identifying pathologic myocardial changes in various conditions. Easy integration into existing setups as a postprocessing algorithm may facilitate broader access to myocardial tissue characterization. Keywords: MRI, Cardiomyopathies, Tissue Characterization Supplemental material is available for this article. © RSNA, 2025.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Schroth D, Essert G, Hansmann J, et al. Feasibility of Gadolinium-enhanced T1* Ratio Mapping for Myocardial Tissue Characterization. Radiol Cardiothorac Imaging. 2025. PMID: 40503987. doi:10.1148/ryct.240060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。